Medicare’s blame game
A Stanford researcher and his colleague got access to data showing the inner workings of an influential committee advising Medicare. They found that bias among its members has different effects from what critics claim.
Exome sequencing program launched
The Clinical Genomics Program, which began as a pilot program a few years ago, offers whole-exome sequencing and analysis to patients with undiagnosed genetic diseases.
Conference on human immune monitoring
The two-day event will highlight the latest research by top scientists on technologies and analytic methods geared toward studying human immunology.
Mysterious skeleton reveals details of bone diseases
The strange skeletal remains of a fetus discovered in Chile have turned up new insights into the genetics of some bone diseases, according to a new study from researchers at Stanford and UCSF.
Finance town hall set for April 3
The event will be an opportunity to learn more about the sources and uses of the school’s funds.
Faculty join clinician-researcher honor society
Four Stanford Medicine clinician-researchers were elected to the medical honor society.
Protein clumps affect neural stem cells
Young, resting neural stem cells have large protein clumps often associated with neurodegeneration. As stem cells age, the aggregates inhibit their ability to make new neurons, Stanford researchers say.
Ethics review needed for AI use in health care
In a perspective piece, Stanford researchers discuss the ethical implications of using machine-learning tools in making health care decisions for patients.
Symposium to tackle AI balance in medicine
The Presence Center is hosting a daylong symposium April 17 on issues surrounding humans and machines in medicine.
Neuroanatomy lab bridges virtual reality, OR
Stanford’s Department of Neurosurgery has a new anatomy lab next door to its virtual reality center. Together, the labs are a valuable resource for trainees and surgeons alike.
Grants announced to investigate IBD
Eight Stanford Medicine researchers have received grants from the Kenneth Rainin Foundation to investigate inflammatory bowel disease.
Predicting success of lung cancer drug
With the help of a new radioactive tracer, doctors can predict with more than 80 percent accuracy how well a widely-used lung cancer drug will combat tumors, according to researchers at Stanford.
Leading in Precision Health
Stanford Medicine is leading the biomedical revolution in precision health, defining and developing the next generation of care that is proactive, predictive and precise.
A Legacy of Innovation
Stanford Medicine's unrivaled atmosphere of breakthrough thinking and interdisciplinary collaboration has fueled a long history of achievements.